Search

Memorial Medical Care, PC, a practice of Memorial Sloan Kettering Cancer Center physicians, in collaboration with New York Cancer & Blood Specialists (NYCBS), recently announced the opening of a new comprehensive cancer care practice in the Flatbush section of Brooklyn.

… Wednesday, January 4, 2023 New York Cancer & Blood Specialists (NYCBS), one of the fastest-growing community oncology practices in the nation, today announced the opening of a new comprehensive cancer care practice in the Flatbush section of Brooklyn in collaboration with Memorial Medical Care, PC (MMC

The Memorial Sloan Kettering Cancer Center (MSK) community extends our congratulations to Board of Trustees member David M. Rubenstein, who received the Presidential Medal of Freedom — the nation’s highest civilian honor — earlier this month.

… Wednesday, January 22, 2025 David M. Rubenstein The Memorial Sloan Kettering Cancer Center (MSK) community extends our congratulations to Board of Trustees member David M. Rubenstein, who received the Presidential Medal of Freedom — the nation’s highest civilian honor — earlier this month. During a ceremony

A carefully monitored, multidisciplinary watch-and-wait strategy can result in excellent rectal preservation and pelvic tumor control for a large majority of select patients with rectal cancer who show a clinical complete response after neoadjuvant therapy.

… Friday, March 1, 2019 A carefully monitored, multidisciplinary watch-and-wait strategy can result in excellent rectal preservation and pelvic tumor control for a large majority of select patients with rectal cancer who show a clinical complete response after neoadjuvant therapy, according to our recent

MSK investigators are learning how cancer cells escape from the original tumor and hide out in the body. Their goal is to prevent metastatic tumors from forming.

… Friday, December 1, 2017 Summary Investigators at Memorial Sloan Kettering are conducting research to figure out how cancer cells are able to escape from the original tumor and hide out in the body. Their ultimate goal is to find ways to prevent metastatic tumors from forming. Cancer metastasis occurs

Read about an FDA approval for immunotherapy to treat head and neck squamous cell carcinoma.

… Wednesday, October 1, 2025 People with locally advanced  head and neck squamous cell carcinoma (HNSCC) now have a new treatment option that could extend their lives with fewer side effects. The  U.S. Food and Drug Administration (FDA) has approved the immunotherapy drug  pembrolizumab (Keytruda® ) to

The June 29 edition of “MSK Science Spotlight” will feature chemical biologist Yael David, PhD, “Uncovering Epigenetic Events that Drive Oncogenesis.

… Monday, June 29, 2020 The June 29 edition of “ MSK Science Spotlight ” will feature chemical biologist Yael David, PhD, “Uncovering Epigenetic Events that Drive Oncogenesis.” A member of Sloan Kettering Institute , Dr. David develops and applies methods in chemical biology toward studying epigenetic

At Memorial Sloan Kettering Cancer Center’s 45th annual ceremony, graduating master's and PhD students were honored and award winners were recognized.

… Friday, May 17, 2024 GSK master’s degree recipients with members of the platform party GSK master’s degree recipients with members of the platform party. Back row, from left: Dr. Urvi Ajay Shah, Dr. Michael Scordo, Dr. Ioannis Politikos, Dr. Ivan Sergueivich Kotchetkov, and Dr. Vance Broach. Front row

Zeda Zhang was recently awarded the Predoctoral to Postdoctoral Fellow Transition Award from the National Cancer Institute (NCI).

… Friday, November 17, 2017 Summary Zeda Zhang was recently honored with an award from the NCI for his work addressing drug resistance in prostate cancer care. Zeda Zhang was recently awarded the Predoctoral to Postdoctoral Fellow Transition Award from the National Cancer Institute (NCI). The nationally

New MSK research reveals how dormant metastatic cancer cells protect themselves from the immune system by changing their shape.

… Thursday, January 15, 2026 Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune defenders and biding their time until conditions are ripe for establishing a new tumor elsewhere in the body, a process known as metastasis. The vast majority

Discoveries made at Memorial Sloan Kettering receive recognition at the 2014 Annual Meeting of the American Association for Cancer Research.

… Thursday, April 10, 2014 Summary Discoveries made at Memorial Sloan Kettering receive recognition at the 2014 Annual Meeting of the American Association for Cancer Research. Two Memorial Sloan Kettering studies about targeted cancer therapies received recognition in the press program for one of the nation